Johnson Controls International (JCI) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
8 Jun, 2026Executive summary
Achieved 7% year-over-year sales growth to $5.8 billion, with organic sales up 6% and broad-based strength across all regions and segments.
Adjusted EBIT margin expanded by 190 basis points to 12.4%, and adjusted EPS rose nearly 40% year-over-year to $0.89, exceeding guidance.
Orders grew 39% year-over-year, with record backlog up 20% to $18.2 billion, driven by strong demand in data centers and robust contributions from all regions.
Advanced portfolio with innovations in cooling and connectivity, and completed sale of ADT Mexico Security business, recognizing a $70 million pre-tax gain.
Significant one-time items included $130 million in insurance recoveries related to AFFF litigation.
Financial highlights
Gross profit reached $2.07 billion, with gross margin improving to 35.8% year-over-year.
Operating income before taxes was $708 million, up from $408 million year-over-year.
Free cash flow was $531 million; adjusted free cash flow was $428 million, with conversion at 77%.
Net debt at quarter-end was $9.15 billion, with net debt to adjusted EBITDA at 2.2x.
SG&A expenses decreased 13% to $1.2 billion, primarily due to insurance recoveries and divestiture gains.
Outlook and guidance
Q2 2026 guidance: organic sales growth ~5%, operating leverage ~45%, adjusted EPS ~$1.11.
FY26 guidance: mid-single-digit organic sales growth, operating leverage ~50%, adjusted EPS ~$4.70 (raised from ~$4.55), and adjusted free cash flow conversion ~100%.
Backlog grew 20% year-over-year to $18.2 billion, with orders up 39%, led by strong demand in data center projects.
Restructuring plan expected to be completed by fiscal 2027, targeting $500 million in annual cost savings.
Latest events from Johnson Controls International
- Q3 delivered growth, margin expansion, record backlog, and major divestitures amid portfolio shift.JCI
Q3 20248 Jun 2026 - Q4 organic sales up 10%, margin expansion, record backlog, and strong FY25 outlook.JCI
Q4 20248 Jun 2026 - Q1 2025 saw 10% organic growth, 39% EPS gain, and raised full-year guidance.JCI
Q1 20258 Jun 2026 - Q2 2025 saw 7% organic sales growth, margin expansion, and raised FY25 guidance.JCI
Q2 20258 Jun 2026 - Q3 saw 6% organic sales growth, record backlog, and expanded share repurchase authorization.JCI
Q3 20258 Jun 2026 - Record backlog, strong execution, and robust capital returns set up double-digit EPS growth in 2026.JCI
Q4 20258 Jun 2026 - Q2 saw 8% sales growth, 45% adjusted EPS growth, and record backlog, prompting raised guidance.JCI
Q2 20268 Jun 2026 - Innovation and operational excellence drive high single-digit organic growth and service expansion.JCI
Analyst Day 20265 Jun 2026 - Strong order growth, margin gains, and strategic focus drive optimism for future performance.JCI
19th Annual Global Transportation & Industrials Conference20 May 2026